What is Novo Nordisk's current operating income?

127.66 billion DKK, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95).

When did Novo Nordisk's operating income last change?

The latest value on the record is 127.66 billion DKK, dated December 31, 2025; before it the record holds 128.34 billion DKK, dated December 31, 2024 and closed on December 31, 2025.

What was Novo Nordisk's operating income before 127.66 billion DKK?

128.34 billion DKK, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov).

organization · fact

Novo Nordisk operating income

As of November 9, 2026, Novo Nordisk's operating income on the AsOf record is 127.66 billion DKK, dated December 31, 2025, from a primary source (sec.gov).

current operating income: 127.66 billion DKKDecember 31, 2025 · 1 source

7 dated values, oldest first; the current one in colour. In DKK.

Every dated value

7 values · 1 current · supersededA later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.More in About →

Novo Nordisk operating income: every dated value on the record, oldest first, with its dates, status, confidence and sources
value	valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →	valid to	confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →	sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →
52.48 billion DKK: operating income 52,483,000,000 DKK from 2019-12-31, claim clm_B2B75C38DC99 and its sources (superseded) to 2020-12-31 · sec.gov	2019-12-31	2020-12-31	0.95	sec.gov
54.13 billion DKK: operating income 54,126,000,000 DKK from 2020-12-31, claim clm_D272A9AE2D76 and its sources (superseded) to 2021-12-31 · sec.gov	2020-12-31	2021-12-31	0.95	sec.gov
58.64 billion DKK: operating income 58,644,000,000 DKK from 2021-12-31, claim clm_4E462623C749 and its sources (superseded) to 2022-12-31 · sec.gov	2021-12-31	2022-12-31	0.95	sec.gov
74.81 billion DKK: operating income 74,809,000,000 DKK from 2022-12-31, claim clm_F3418E0D3161 and its sources (superseded) to 2023-12-31 · sec.gov	2022-12-31	2023-12-31	0.95	sec.gov
102.57 billion DKK: operating income 102,574,000,000 DKK from 2023-12-31, claim clm_792EA3966BEF and its sources (superseded) to 2024-12-31 · sec.gov	2023-12-31	2024-12-31	0.95	sec.gov
128.34 billion DKK: operating income 128,339,000,000 DKK from 2024-12-31, claim clm_109041F6F3C0 and its sources (superseded) to 2025-12-31 · sec.gov	2024-12-31	2025-12-31	0.95	sec.gov
127.66 billion DKK: operating income 127,658,000,000 DKK from 2025-12-31, claim clm_672756B8F8A9 and its sources to present · sec.gov	2025-12-31	present	0.95	sec.gov

What replaced what

6 replacements

52.48 billion DKK2019-12-31 to 2020-12-31→54.13 billion DKKfrom 2020-12-31
54.13 billion DKK2020-12-31 to 2021-12-31→58.64 billion DKKfrom 2021-12-31
58.64 billion DKK2021-12-31 to 2022-12-31→74.81 billion DKKfrom 2022-12-31
74.81 billion DKK2022-12-31 to 2023-12-31→102.57 billion DKKfrom 2023-12-31
102.57 billion DKK2023-12-31 to 2024-12-31→128.34 billion DKKfrom 2024-12-31
128.34 billion DKK2024-12-31 to 2025-12-31→127.66 billion DKKfrom 2025-12-31

Questions this record answers

What is Novo Nordisk's current operating income?: 127.66 billion DKK, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95).
When did Novo Nordisk's operating income last change?: The latest value on the record is 127.66 billion DKK, dated December 31, 2025; before it the record holds 128.34 billion DKK, dated December 31, 2024 and closed on December 31, 2025.
What was Novo Nordisk's operating income before 127.66 billion DKK?: 128.34 billion DKK, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov).

Answered from the rows above, as of November 9, 2026.

Cite Novo Nordisk operating income

Each form names the value, its as-of date (2025-12-31), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text

AsOf. "Novo Nordisk operating income: 127,658,000,000 DKK", as of 2025-12-31. Claim clm_672756B8F8A9, https://asof.is/claim/clm_672756B8F8A9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.

APA

AsOf. (2025). Novo Nordisk operating income: 127,658,000,000 DKK (as of 2025-12-31) [Record clm_672756B8F8A9]. Retrieved November 9, 2026, from https://asof.is/claim/clm_672756B8F8A9 (source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm)

BibTeX

@misc{asof_clm_672756B8F8A9,
  author = {AsOf},
  title = {Novo Nordisk operating income: 127,658,000,000 DKK},
  year = {2025},
  howpublished = {\url{https://asof.is/claim/clm_672756B8F8A9}},
  note = {Claim clm\_672756B8F8A9, as of 2025-12-31; source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm},
  urldate = {2026-11-09}
}

Read on

/record/novo-nordisk/operating_income.md · this page as markdown
/record/novo-nordisk · /timelines/novo-nordisk

Other facts about Novo Nordisk

Record

Novo Nordisk operating income

As of November 9, 2026, Novo Nordisk's operating income on the AsOf record is 127.66 billion DKK, dated December 31, 2025, from a primary source (sec.gov).

current operating income

127.66 billion DKKDecember 31, 2025 · 1 source

7 dated values, oldest first; the current one in colour. In DKK.

Every dated value

7 values · 1 current · supersededA later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.More in About →

value

valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →

52.48 billion DKK

to 2020-12-31 · sec.gov

2019-12-31

54.13 billion DKK

to 2021-12-31 · sec.gov

2020-12-31

58.64 billion DKK

to 2022-12-31 · sec.gov

2021-12-31

74.81 billion DKK

to 2023-12-31 · sec.gov

2022-12-31

102.57 billion DKK

to 2024-12-31 · sec.gov

2023-12-31

128.34 billion DKK

to 2025-12-31 · sec.gov

2024-12-31

127.66 billion DKK

to present · sec.gov

2025-12-31

Questions this record answers

What is Novo Nordisk's current operating income?: 127.66 billion DKK, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95).
When did Novo Nordisk's operating income last change?: The latest value on the record is 127.66 billion DKK, dated December 31, 2025; before it the record holds 128.34 billion DKK, dated December 31, 2024 and closed on December 31, 2025.
What was Novo Nordisk's operating income before 127.66 billion DKK?: 128.34 billion DKK, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov).

Answered from the rows above, as of November 9, 2026.

Cite Novo Nordisk operating income

Plain text

AsOf. "Novo Nordisk operating income: 127,658,000,000 DKK", as of 2025-12-31. Claim clm_672756B8F8A9, https://asof.is/claim/clm_672756B8F8A9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.

APA

AsOf. (2025). Novo Nordisk operating income: 127,658,000,000 DKK (as of 2025-12-31) [Record clm_672756B8F8A9]. Retrieved November 9, 2026, from https://asof.is/claim/clm_672756B8F8A9 (source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm)

BibTeX

@misc{asof_clm_672756B8F8A9,
  author = {AsOf},
  title = {Novo Nordisk operating income: 127,658,000,000 DKK},
  year = {2025},
  howpublished = {\url{https://asof.is/claim/clm_672756B8F8A9}},
  note = {Claim clm\_672756B8F8A9, as of 2025-12-31; source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm},
  urldate = {2026-11-09}
}